Selective ET(A) receptor antagonism reduces neointimal hyperplasia in a porcine coronary stent model

Circulation

Volumn 97, Issue 25, 1998, Pages 2551-2556

  McKenna, Charles J ^a   Burke, Sandra E ^b,c   Opgenorth, Terry J ^b,c   Padley, Robert J ^b,c   Camrud, Ladonna J ^a   Camrud, Allan R ^a   Johnson, Jodi ^a   Carlson, Paula J ^a   Lerman, Amir ^a   Holmes Jr , David R ^a   Schwartz, Robert S ^a,d  

^a EMORY UNIVERSITY HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

^c ABBOTT LABORATORIES   (United States)

^d Mayo Clinic   (United States)

Author keywords

Angioplasty; Endothelin; Restenosis

Indexed keywords

ABT 147627; ENDOTHELIN A RECEPTOR ANTAGONIST; PLACEBO; UNCLASSIFIED DRUG;

ANGIOPLASTY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; DOSE RESPONSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RESTENOSIS; REVASCULARIZATION; SMOOTH MUSCLE FIBER; STATISTICAL ANALYSIS; STENT; SWINE; THROMBOSIS;

EID: 0032581009     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.25.2551     Document Type: Article

References (38)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1998;332:411-415.
2. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T, The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA. 1989;86:2863-2867.
3. Sakurai T, Yanagisawa M, Masaki T. Molecular characterisation of the endothelin receptors. Trends Pharmacol Sci. 1992;13:103-108.
4. Tamirisa P, Frishman WH, Kumar A. Endothelin and endothelin antagonism: roles in cardiovascular health and disease. Am Heart J. 1995;130:601-610.
5. Ohnishi A, Yamaguchi K, Kusuhara M, Abe K, Kimura S. Mobilization of intracellular calcium by ET in Swiss 3T3 cells. Biochem Biophys Res Commun. 1989;161:489-495.
6. Vigne P, Marsault R, Breittmayer JP, Frelin C. Endothelin stimulates phosphatidylinositol hydrolysis and DNA synthesis in brain capillary endothelial cells. Biochem J. 1990;266:415-420.
7. Bobik A, Grooms A, Millar JA, Mitchell A, Grinpukel S. Growth factor activity of endothelin on vascular smooth muscle. Am J Physiol. 1990;258:C408-C415.
8. Rigel DF, Lappe RW. Differential responsiveness of conduit and resistance coronary arteries to endothelin A and B receptor stimulation in anesthetized dogs. J Cardiovasc Pharmacol. 1993;22:5243-5247.
9. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 1990;348:730-732.
10. Ohlstein EH, Arleth A, Bryan H, Elliott JD, Sung CP. The selective endothelin ETA receptor antagonist BQ123 antagonizes endothelin-1 mediated mitogenesis. Eur J Pharmacol. 1992;225:347-350.
11. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med. 1991;325:997-1001.
12. Bacon CR, Gary NRB, Davenport AP. Endothelin peptide and receptors in human atherosclerotic coronary artery and aorta. Circ Res. 1996;79:794-801.
13. Tahara A, Kohno M, Yanagi S, Itagane H, Toda I, Akioka K, Teregaki M, Yasuda M, Takeuchi K, Takeda T. Circulating immunoreactive endothelin in patients undergoing percutaneous transluminal coronary angioplasty. Metabolism. 1991;40:1235-1237.
14. Hasdai D, Holmes DR, Garratt KN, Edwards WD, Lerman A. Mechanical pressure and stretch release endothelin-1 from human atherosclerotic coronary arteries in vivo. Circulation. 1997;95:357-362.
15. Trachtenberg JD, Sun S, Choi ET, Callow AD, Ryan U. Effect of endothelin-1 infusion on the development of intimal hyperplasia after balloon catheter injury. J Cardiovasc Pharmacol. 1993;22:355-359.
16. Douglas SA, Louden C, Vickery-Clark LM, Storer BL, Hart T, Feuerstein GZ, Elliott JD, Ohlstein EH. A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty: protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670. Circ Res. 1994;75:190-197.
17. Ferrer P, Valentine M, Jenkins-West, Weber H, Goller NL, Durham SK, Molloy CJ, Moreland S. Orally active endothelin receptor antagonist BMS-182874 suppresses neointimal development in balloon-injured rat carotid arteries. J Cardiovasc Pharmacol. 1995;26:908-915.
18. Burke SE, Lubbers NL, Gagne GD, Wessale JL, Wegner CD, Opgenorth TJ. Selective antagonism of the ETA receptor reduces neointimal hyperplasia after balloon-induced vascular injury in pigs. J Cardiovasc Pharmacol. In press.
19. Schwartz RS, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR. Restenosis after balloon angioplasty: a practical proliferative model in porcine coronary arteries. Circulation. 1990;82:2190-2200.
20. Schwartz RS, Edwards WD, Bailey KR, Camrud AR, Jorgenson MA, Holmes DR. Differential neointimal response to coronary artery injury in pigs and dogs: implications for restenosis models. Arterioscler Thromb. 1994;14:395-400.
21. Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR, Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol. 1992;19:267-274.
22. Karas SP, Gravanis MB, Santoian EC, Robinson KA, Anderberg KA, King SB. Coronary intimal proliferation after balloon injury and stenting in swine: an animal model of restenosis. J Am Coll Cardiol. 1992;20:467-474.
23. Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF, Kent KM, Griffin J, Leon MB. Patterns and mechanisms of in-stent restenosis: a serial ultrasound study. Circulation. 1996;94:1247-1254.
24. Mudra H, Regar E, Klauss V, Werner F, Henneke KH, Sbarouni E, Theisen K. Serial follow-up after optimized ultrasound-guided deployment of Palmaz-Schatz stems. Circulation. 1997;95:363-370.
25. Kearney M, Pieczek A, Haley L, Losordo DW, Andres V, Schainfeld R, Rosenfield K, Isner JM. Histopathology of in-stent restenosis in patients with peripheral artery disease. Circulation. 1997;95:1998-2002.
26. DeRuiter MC, Poelmann RE, VanMunsteren JC, Mironov V, Markwald RR, Gittenberger-deGroot AC. Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ Res. 1997;80:444-451.
27. Mathew V, Hasdai D, Lerman A. The role of endothelin in coronary atherosclerosis. Mayo Clin Proc. 1996;71:769-777.
28. Rubanyi GM. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol. 1993;22:1-14.
29. Battistini B, Chailler P, D'Orleans-Juste P, Briere N, Sirois P. Growth regulatory properties of endothelins. Peptides. 1993;14:385-399.
30. Levin ER. Endothelins. N Engl J Med. 1995;333:356-363.
31. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250.
32. Boulanger CM, Tanner FC, Bea ML, Hahn AWA, Werner A, Luscher TF. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res. 1992;70:1191-1197.
33. Azuma H, Hamasaki H, Niimi Y, Terada T, Matsubara O. Role of endothelin-1 in neointima formation after endothelial removal in rabbit carotid arteries. Am J Physiol. 1994;267:H2259-H2267.
34. Wang X, Douglas SA, Louden C, Vickery-Clark LM, Feuerstein GZ, Ohlstein EH. Expression of endothelin-1. endothelin-3, endothelin-converting enzyme-1, and endothelin-A and endothelin-B receptor mRNA after angioplasty-induced neointimal formation in the rat. Circ Res. 1996;78:322-328.
35. Pollman MJ, Yamada T, Horiuchi M, Gibbons GH. Vasoactive substances regulate vascular smooth cell apoptosis: countervailing influences of nitric oxide and angiotensin II. Circ Res. 1996;79:748-756.
36. Schwartz RS, Holmes DR, Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol. 1992;20:1284-1293.
37. Rizvi MAD, Katwa L, Spadone DP, Myers PR. The effects of endothelin-1 on collagen type I and type III synthesis in cultured porcine coronary artery vascular smooth muscle cells. J Mol Cell Cardiol. 1996:28:243-252.
38. Shi Y, O'Brien JE, Fard A, Mannion JD, Wang D, Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation. 1996;94:1655-1664.